Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA Slams Actelion Amid BMS Buyout Rumors
Motley Fool
Thursday, October 7, 2010 - 6:03pm
tags:
Bristol-Myers Squibb, FDA, Actelion, M&A, Tracleer, Ventavis
Genzyme: Exploring Alternatives, WSJ Says
Barron's
Thursday, October 7, 2010 - 4:28pm
tags:
M&A, Genzyme, Pfizer, GSK, JNJ, Sanofi
Beyond the Bluster, What Value in Standalone Genzyme?
WSJ Online
Thursday, October 7, 2010 - 12:04pm
tags:
Genzyme, Sanofi, M&A
Affymax shares dip on patent ruling
Bizjournals.com
Thursday, October 7, 2010 - 11:56am
tags:
patents, Affymax, anemia, Hematide, JNJ
Targacept says ADHD drug fails in study
Yahoo/AP
Thursday, October 7, 2010 - 11:54am
tags:
Targacept, ADHD, AstraZeneca
Novartis to pay Gilenya patients' bills
Fierce Pharma
Thursday, October 7, 2010 - 11:52am
tags:
Novartis, Gilenya, MS, multiple sclerosis
Want To Milk A Cash Cow? Try Pediatric Exclusivity
Pharmalot
Thursday, October 7, 2010 - 11:51am
tags:
pediatrics, pediatric exclusivity
Actelion Pharma Failed To Report 3,500 Deaths
Pharmalot
Thursday, October 7, 2010 - 11:49am
tags:
Actelion, FDA, adverse events, Tracleer, Ventavis
Should You Buy It?: Anthera Pharmaceuticals
Motley Fool
Thursday, October 7, 2010 - 11:42am
tags:
Anthera, acute coronary syndrome, lupus
Genzyme's Defense Against Hostile Sanofi Takeover Is Time
Bloomberg
Thursday, October 7, 2010 - 11:41am
tags:
hostile bid, Sanofi, M&A, Genzyme
Vical signs deal to make HIV vaccines
Yahoo/AP
Thursday, October 7, 2010 - 8:11am
tags:
Vical, vaccines, HIV
Those Pharma Job Cuts Just Keep On Coming
Pharmalot
Thursday, October 7, 2010 - 8:10am
tags:
layoffs
Novartis, Synthetic Genomics in flu vaccine deal
Marketwatch
Thursday, October 7, 2010 - 8:08am
tags:
vaccines, Synthetic Genomics, Novartis, flu vaccine
Sucampo, Abbott file in Japan on constipation drug
Marketwatch
Thursday, October 7, 2010 - 8:07am
tags:
Abbott Laboratories, Sucampo, Japan, constipation, Amitiza
China Demand to Help Increase Global Drug Sales to $880 Billion, IMS Says
Bloomberg
Thursday, October 7, 2010 - 7:06am
tags:
China, drug sales
Will Jazz's Rekinla Get FDA's OK?
Motley Fool
Thursday, October 7, 2010 - 7:03am
tags:
Jazz Pharmaceuticals, Rekinla, FDA, fibromyalgia
Biocon May Sell Oral Diabetes Drug to Pfizer, Bloomberg UTV Says
Bloomberg
Thursday, October 7, 2010 - 7:01am
tags:
Biocon, Pfizer, diabetes, insulin
InterMune sells Hep C drug rights to Roche
Marketwatch
Wednesday, October 6, 2010 - 6:54pm
tags:
hepatitis C, InterMune, Roche, danoprevir
Court Says Teva Can Challenge Eisai Patents, Hurting Indian Rival Ranbaxy
Bloomberg
Wednesday, October 6, 2010 - 6:52pm
tags:
Teva Pharmaceuticals, India, Eisai, patents, Ranbaxy
Why Some Pharmaceutical Sales Managers Hate to Manage Professional Representatives
Pharmareform
Wednesday, October 6, 2010 - 6:47pm
tags:
sales managers, drug reps

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.